Common Questions
Frequently Asked Questions
Everything you need to know about our specialty polymers and biomedical solutions.
Expert Support
Technical Guidance
Partnership Ready
SRDK Biochemicals Pvt Ltd is a specialty chemicals and polymer company developing
advanced materials for drug delivery, 3D bioprinting, and high‑value biomedical
applications. We focus on bioabsorbable and functional polymers that help partners
translate ideas into clinically relevant products.
Our corporate headquarters and manufacturing operations are located at F26, FLO-TSIIC Industrial Park, Medical Devices Park, Ameenpur, Hyderabad, Telangana - 502319
Our mission is to engineer next‑generation polymer platforms that enable safer, more
effective, and more patient‑centric therapies. Our vision is to become a trusted
innovation partner for global pharma, device makers, and research institutions by
combining polymer chemistry with reliable quality systems.
We offer a wide range of biodegradable matrices including polyesters (PLA, PLGA, PCL)
and resorbable polyurethanes. These are designed for oral, injectable, and implantable
systems with sustained and controlled release kinetics.
We develop synthetic and natural polymer systems that function as bioinks, structural
materials, and drug-releasing phases. Our photo-crosslinkable PEG-based hydrogels and
PEG–polyester copolymers are optimized for printability, cell viability, and mechanical
integrity.
Yes. We specialize in custom polymer design where we can tune parameters such as
molecular weight, monomer ratios, end-group chemistry, and architectures to meet
specific release kinetics and processing requirements.
Our platforms include polymers engineered for predictable degradation into non‑toxic
by‑products. We design materials for various routes including transdermal, injectable,
ocular, and long-term implantable delivery.
Our materials are optimized for oral sustained release, long-acting injectables,
localized eluting implants, and transdermal patches, as well as specialized ocular
formulations.
We serve the Global Pharmaceutical & Biotech industry, MedTech OEMs, CDMOs, and Academic
Research Institutions focusing on regenerative medicine and advanced drug delivery.
Yes. We develop hydrogel-based and synthetic bioinks tailored for tissue models,
organ-on-chip applications, and disease models, often integrating controlled-release
agents for enhanced functionality.
Beyond standard platforms, we design specialty polymers with tailored surface chemistry,
stimuli-responsive properties, and mucoadhesive functional groups for targeted delivery.
We provide 3D bioprinted scaffolds and tissue models optimized for preclinical drug
testing and toxicity screening, helping researchers reduce animal testing and improve
drug efficacy predictions.
Yes. We assist partners in scaling formulations and supporting the translation from
bench-scale research to pilot and full-scale commercial manufacturing.
We operate with reliable quality systems to meet stringent performance and regulatory
expectations. Our polymers are manufactured to meet pharmaceutical-grade standards
required for clinical use.
We collaborate with pharmaceutical companies, MedTech OEMs, CDMOs, and academic labs.
You can contact us at info@srdkbiochem.com to discuss custom co-development and
partnership opportunities.
Have More Questions?
Our technical experts are available for in-depth consultations on your specific polymer requirements.